MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

(2015) Lyndsay V. Rhodes et al.   Oncotarget

A new method for stranded whole transcriptome RNA-seq

(2013) David F.B. Miller et al.   METHODS

Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells

(2012) Elizabeth C. Martin et al.   MOLECULAR CARCINOGENESIS

The UCSC Cancer Genomics Browser: update 2013

(2012) Mary Goldman et al.   NUCLEIC ACIDS RESEARCH

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

(2012) A Ward et al.   ONCOGENE

Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors

(2011) Muriel Le Romancer et al.   ENDOCRINE REVIEWS

MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development

(2011) Holger Heyn et al.   INTERNATIONAL JOURNAL OF CANCER

A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells

(2011) Lianguo Kang et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

(2011) Diana M Cittelly et al.   Molecular Cancer

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM

(2010) Charles J. Vaske et al.   BIOINFORMATICS

Epigenetically Deregulated microRNA-375 Is Involved in a Positive Feedback Loop with Estrogen Receptor   in Breast Cancer Cells

(2010) P. de Souza Rocha Simonini et al.   CANCER RESEARCH

MicroRNA-27a Indirectly Regulates Estrogen Receptor α Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells

(2010) Xiangrong Li et al.   ENDOCRINOLOGY

The UCSC cancer genomics browser: update 2011

(2010) J. Zachary Sanborn et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

(2010) X Rao et al.   ONCOGENE

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

(2010) Sheng-Li Lin et al.   PLoS One

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

(2009) R Spizzo et al.   CELL DEATH AND DIFFERENTIATION

Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation

(2009) Nabanita S. Datta et al.   CELLULAR SIGNALLING

Estrogen receptor-alpha (ER-α) suppresses expression of its variant ER-α36

(2009) Yi Zou et al.   FEBS LETTERS

Many roads to maturity: microRNA biogenesis pathways and their regulation

(2009) Julia Winter et al.   NATURE CELL BIOLOGY

MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer

(2008) Jian-Jun Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1

(2008) Tyler E. Miller et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

PID: the Pathway Interaction Database

(2008) Carl F. Schaefer et al.   NUCLEIC ACIDS RESEARCH